Effects of DHEA on metabolic and endocrine functions of adipose tissue

Hormone Molecular Biology and Clinical Investigation

Volumn 14, Issue 2, 2013, Pages 65-74

  Karbowska, Joanna ^a   Kochan, Zdzislaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adipokines; Adipose tissue; Dehydroepiandrosterone; Insulin sensitivity; Lipid metabolism

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ACYL COENZYME A DESATURASE; ADIPONECTIN; ANDROGEN RECEPTOR; CORTICOSTEROID; CORTISONE; HORMONE SENSITIVE LIPASE; HYDROCORTISONE; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRASTERONE; RESISTIN; SEX HORMONE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; ADIPOCYTOKINE; GLUCOSE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANDROGEN DEFICIENCY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; ENDOCRINE FUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYDROLYSIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID HYDROLYSIS; LIPID METABOLISM; LIPID STORAGE; METABOLIC REGULATION; NONHUMAN; OBESITY; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; TISSUE DIFFERENTIATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ADIPOGENESIS; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CELL PROLIFERATION; DEHYDROEPIANDROSTERONE; GLUCOSE; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; TRIGLYCERIDES;

EID: 84915771535     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2013-0009     Document Type: Review

References (81)

1. Butenandt A, Dannenbaum H. Isolierung eines neuen, physiologisch unwirksamen Sterinderivates aus Männerharn, seine Verknüpfung mit Dehydro-androsteron und Androsteron: ein Beitrag zur Konstitution des Androsterons. Z Physiol Chem 1934;229:192-5.
2. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992;75:1002-4.
3. Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci 1995;774:128-42. (Pubitemid 26140365)
4. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-402. (Pubitemid 27337846)
5. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO Jr, Pearson TA. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-70. (Pubitemid 20353406)
6. Yamaguchi Y, Tanaka S, Yamakawa T, Kimura M, Ukawa K, Yamada Y, Ishihara M, Sekihara H. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol 1998;49:377-83. (Pubitemid 28448949)
7. Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96:1642-53.
8. MacKenzie SM, Huda SS, Sattar N, Fraser R, Connell JM, Davies E. Depot-specific steroidogenic gene transcription in human adipose tissue. Clin Endocrinol 2008;69:848-54.
9. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 1998;63:319-21. (Pubitemid 28265669)
10. Wang F, Koskela A, Hamalainen E, Turpeinen U, Savolainen- Peltonen H, Mikkola TS, Vihma V, Adlercreutz H, Tikkanen MJ. Quantitative determination of dehydroepiandrosterone fatty acyl esters in human female adipose tissue and serum using mass spectrometric methods. J Steroid Biochem Mol Biol 2011;124:93-8.
11. Marwah A, Gomez FE, Marwah P, Ntambi JM, Fox BG, Lardy H. Redox reactions of dehydroepiandrosterone and its metabolites in differentiating 3T3-L1 adipocytes: a liquid chromatographicmass spectrometric study. Arch Biochem Biophys 2006;456:1-7. (Pubitemid 44820023)
12. Mo Q, Lu SF, Simon NG. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 2006;99:50-8.
13. Shimizu T, Szalay L, Hsieh YC, Suzuki T, Choudhry MA, Bland KI, Chaudry IH. A role of PPAR-γ in androstenediol-mediated salutary effects on cardiac function following traumahemorrhage. Ann Surg 2006;244:131-8. (Pubitemid 44297457)
14. Karbowska J, Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPARγ. Biochem Pharmacol 2005;70:249-57. (Pubitemid 40814407)
15. Karbowska J, Kochan Z. Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue. Steroids 2012;77:1359-65.
16. Fujioka K, Kajita K, Wu Z, Hanamoto T, Ikeda T, Mori I, Okada H, Yamauchi M, Uno Y, Morita H, Nagano I, Takahashi Y, Ishizuka T. Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor. Am J Physiol Endocrinol Metab 2012;302:E694-704.
17. Kochan Z, Karbowska J. Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol Cell Endocrinol 2004;218:57-64. (Pubitemid 38569927)
18. Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Am J Physiol Endocrinol Metab 2005;288:E957-64. (Pubitemid 40547890)
19. Tamasi V, Miller KK, Ripp SL, Vila E, Geoghagen TE, Prough RA. Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor α by dehydroepiandrosterone and other peroxisome proliferators. Mol Pharmacol 2008;73:968-76. (Pubitemid 351397901)
20. Altman R, Motton DD, Kota RS, Rutledge JC. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARα and NF-κB. Vascul Pharmacol 2008;48:76-84.
21. Liu D, Iruthayanathan M, Homan LL, Wang Y, Yang L, Wang Y, Dillon JS. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signalregulated kinase 1/2-mediated mechanisms. Endocrinology 2008;149:889-98. (Pubitemid 351397920)
22. Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 2004;151:1-14. (Pubitemid 39117360)
23. Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57-61. (Pubitemid 18027729)
24. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol 1998;49:421-32. (Pubitemid 28475333)
25. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. J Am Med Assoc 2004;292:2243-8. (Pubitemid 39473162)
26. Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging 2011;3:533-42.
27. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7. (Pubitemid 24181005)
28. Jankowski CM, Gozansky WS, Van Pelt RE, Wolfe P, Schwartz RS, Kohrt WM. Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids. Clin Endocrinol 2011;75:456-63.
29. Hansen PA, Han DH, Nolte LA, Chen M, Holloszy JO. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Physiol 1997;273:R1704-8. (Pubitemid 27518122)
30. Tagliaferro AR, Ronan AM, Payne J, Meeker LD, Tse S. Increased lipolysis to β-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Physiol 1995;268:R1374-80.
31. Sanchez J, Perez-Heredia F, Priego T, Portillo MP, Zamora S, Garaulet M, Palou A. Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity. J Nutr Biochem 2008;19:809-18.
32. Rice SP, Zhang L, Grennan-Jones F, Agarwal N, Lewis MD, Rees DA, Ludgate M. Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Mol Cell Endocrinol 2010;320:51-7.
33. Lea-Currie YR, Wen P, McIntosh MK. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1998;248:497-504. (Pubitemid 28404449)
34. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissuespecific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252-6. (Pubitemid 38089312)
35. Gomez FE, Miyazaki M, Kim YC, Marwah P, Lardy HA, Ntambi JM, Fox BG. Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Biochemistry 2002;41:5473-82. (Pubitemid 34436086)
36. Hernandez-Morante JJ, Perez-de-Heredia F, Lujan JA, Zamora S, Garaulet M. Role of DHEA-S on body fat distribution: gender- and depot-specific stimulation of adipose tissue lipolysis. Steroids 2008;73:209-15.
37. Klein S, Young VR, Blackburn GL, Bistrian BR, Wolfe RR. Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects. J Clin Invest 1986;78:928-33. (Pubitemid 17177072)
38. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006;281:40236-41. (Pubitemid 46041828)
39. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011;50: 14-27.
40. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004;306:1383-6. (Pubitemid 39532517)
41. Fredrikson G, Stralfors P, Nilsson NO, Belfrage P. Hormonesensitive lipase of rat adipose tissue. Purification and some properties. J Biol Chem 1981;256:6311-20. (Pubitemid 11058063)
42. Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, Sattler W, Magin TM, Wagner EF, Zechner R. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 2002;277:4806-15. (Pubitemid 34968514)
43. Miyoshi H, Perfield JW II, Obin MS, Greenberg AS. Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 2008;105:1430-6.
44. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 2004;279:47066-75. (Pubitemid 39518362)
45. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006;312:734-7.
46. Yajima H, Kobayashi Y, Kanaya T, Horino Y. Identification of peroxisome-proliferator responsive element in the mouse HSL gene. Biochem Biophys Res Commun 2007;352:526-31. (Pubitemid 44838517)
47. Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E, Holm C. Identification of novel phosphorylation sites in hormonesensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 1998;273:215-21. (Pubitemid 28042196)
48. Mauriege P, Martel C, Langin D, Lacaille M, Despres JP, Belanger A, Labrie F, Deshaies Y. Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism. Metabolism 2003;52:264-72. (Pubitemid 36401669)
49. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001;142:4195-202. (Pubitemid 32907045)
50. Rodriguez-Cuenca S, Carobbio S, Vidal-Puig A. Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses. FASEB J 2012;26:1835-44.
51. Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARγ. Am J Physiol Endocrinol Metab 2006;291:E115-27. (Pubitemid 44035316)
52. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS. PPARγ regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 2007;293:E1736-45. (Pubitemid 350255127)
53. Liu LF, Purushotham A, Wendel AA, Koba K, DeIuliis J, Lee K, Belury MA. Regulation of adipose triglyceride lipase by rosiglitazone. Diabetes Obes Metab 2009;11:131-42.
54. Kimura M, Tanaka S, Yamada Y, Kiuchi Y, Yamakawa T, Sekihara H. Dehydroepiandrosterone decreases serum tumor necrosis factor-α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 1998;139:3249-53. (Pubitemid 28512356)
55. Ishizuka T, Kajita K, Miura A, Ishizawa M, Kanoh Y, Itaya S, Kimura M, Muto N, Mune T, Morita H, Yasuda K. DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. Am J Physiol 1999;276: E196-204. (Pubitemid 29065610)
56. Perrini S, Natalicchio A, Laviola L, Belsanti G, Montrone C, Cignarelli A, Minielli V, Grano M, De Pergola G, Giorgino R, Giorgino F. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 2004;53: 41-52. (Pubitemid 38044696)
57. Ishizuka T, Miura A, Kajita K, Matsumoto M, Sugiyama C, Matsubara K, Ikeda T, Mori I, Morita H, Uno Y, Mune T, Kanoh Y, Ishizawa M. Effect of dehydroepiandrosterone on insulin sensitivity in Otsuka Long-Evans Tokushima-fatty rats. Acta Diabetol 2007;44:219-26. (Pubitemid 350132268)
58. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes 2007;56:753-66. (Pubitemid 46348480)
59. Lasco A, Frisina N, Morabito N, Gaudio A, Morini E, Trifiletti A, Basile G, Nicita-Mauro V, Cucinotta D. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol 2001;145:457-61. (Pubitemid 32927074)
60. Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 2005;54:765-9. (Pubitemid 40322080)
61. Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H, Miyamoto S, Nakano M, Ogawa H. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 2003;88:3190-5. (Pubitemid 36877493)
62. McCormick KL, Wang X, Mick GJ. Evidence that the 11 β-hydroxysteroid dehydrogenase (11 β-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. J Biol Chem 2006;281:341-7. (Pubitemid 43671194)
63. Tagawa N, Minamitani E, Yamaguchi Y, Kobayashi Y. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue. Steroids 2011;76:1546-53.
64. Walker EA, Stewart PM. 11β-Hydroxysteroid dehydrogenase: unexpected connections. Trends Endocrinol Metab 2003;14:334W-9.
65. Hughes KA, Manolopoulos KN, Iqbal J, Cruden NL, Stimson RH, Reynolds RM, Newby DE, Andrew R, Karpe F, Walker BR. Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes 2012;61:1357-64.
66. Kochan Z, Karbowska J, Swierczynski J. The effects of weight cycling on serum leptin levels and lipogenic enzyme activities in adipose tissue. J Physiol Pharmacol 2006;57:115-27. (Pubitemid 46548806)
67. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
68. Friedman JM. Obesity in the new millennium. Nature 2000;404:632-4. (Pubitemid 30205067)
69. Richards RJ, Porter JR, Svec F. Serum leptin, lipids, free fatty acids, and fat pads in long-term dehydroepiandrosteronetreated Zucker rats. Proc Soc Exp Biol Med 2000;223:258-62. (Pubitemid 30337779)
70. Ryu JW, Kim MS, Kim CH, Song KH, Park JY, Lee JD, Kim JB, Lee KU. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem Biophys Res Commun 2003;303:726-31.
71. Perez-de-Heredia F, Sanchez J, Priego T, Nicolas F, Portillo MP, Palou A, Zamora S, Garaulet M. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids 2008;73:1128-36.
72. Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 2001;86:1968-72. (Pubitemid 32472906)
73. Gomez-Santos C, Hernandez-Morante JJ, Tebar FJ, Granero E, Garaulet M. Differential effect of oral dehydroepiandrosteronesulphate on metabolic syndrome features in pre-and postmenopausal obese women. Clin Endocrinol 2012;77:548-54.
74. Pineiro V, Casabiell X, Peino R, Lage M, Camina JP, Menendez C, Baltar J, Dieguez C, Casanueva F. Dihydrotestosterone, stanozolol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not in male samples of omental adipose tissue in vitro: lack of effect of testosterone. J Endocrinol 1999;160:425-32. (Pubitemid 29182834)
75. Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol 2006;57:103-13. (Pubitemid 46548805)
76. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6. (Pubitemid 32756432)
77. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-91.
78. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
79. Hernandez-Morante JJ, Milagro F, Gabaldon JA, Martinez JA, Zamora S, Garaulet M. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 2006;155:593-600. (Pubitemid 44608433)
80. Rice SP, Agarwal N, Bolusani H, Newcombe R, Scanlon MF, Ludgate M, Rees DA. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J Clin Endocrinol Metab 2009;94:1966-72.
81. Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 2004;101:6780-5. (Pubitemid 38586051)